Site search

Ocean Grove gallery has health in its sights News article

A new exhibition series at The Hive gallery in Ocean Grove will raise vital funds to support ophthalmology at the Royal Melbourne Hospital.

LGBTIQA+ inclusive practice

The LGBTIQA+ Patient Liaison team supports LGBTIQA+ safety and inclusion within the hospital environment. We work to improve the experience of all LGBTIQA+ patients, consumers and visitors throughout their hospital journey.

Electronic Medical Record

We use an electronic medical record (EMR) to improve the way we deliver patient care.

Chronic kidney disease education program

People diagnosed with chronic kidney disease (CKD) are carefully monitored during frequent visits to our specialist clinics and attend the CKD education program to prepare for their future care.

Maxillofacial Prosthetics RMH Service

We provide custom-made silicone prostheses that restore malformed or absent parts of the face.

Regional and rural dialysis

Our Kidney Care team acts as a nephrology service provider for 22 regional dialysis units throughout Victoria.

New treatment study for people with lupus Research study

This early-phase study is testing a new treatment for adults with moderate to severe lupus (SLE). The new treatment is a type of antibody designed to help the immune system remove certain B cells that play a role in lupus.

Possible treatment for Parkinson’s disease Research study

Cerevel Therapeutics has begun a study of an experimental drug called CVL-751 as a possible treatment for people with Parkinson’s disease. 

KBL697 for the treatment of ulcerative colitis Research study

Study investigated Lactobacillus gasseri in patients with mild to moderate active ulcerative colitis.

Effects of denosumab on normal breast tissue for BRCA gene carriers Research study

A trial to investigate the effects of denosumab on normal breast tissue in patients with BRCA 1 or 2 mutations and to determine if the drug has the potential to prevent breast cancer.

Spesolimab for the treatment of generalised pustular psoriasis Research study

A study to test whether spesolimab prevents flare-ups in patients with generalised pustular psoriasis.

Spesolimab for the treatment of hidradenitis suppurativa Research study

A study to measure how safe and effective spesolimab (the study drug) is in treating participants with moderate to severe hidradenitis suppurativa (HS).

New drug for moderate to severe hidradenitis suppurativa Research study

A clinical trial to assess the safety and effectiveness of a new drug for hidradenitis suppurativa.

Bimekizumab for the treatment of moderate to severe hidradenitis suppurativa Research study

In this study, we tested whether bimekizumab helps people with a skin disease called hidradenitis suppurativa.

Deferiprone as a treatment for Alzheimer’s disease Research study

A clinical trial to investigate whether deferiprone delays dementia progression in the early stages of dementia.

Ligelizumab for chronic spontaneous urticaria Research study

A clinical trial to assess a new drug called ligelizumab for the treatment of chronic spontaneous urticaria (CSU).

Study hopes to end stigma for people living with type 1 diabetes News article

More than 4 in 5 people with diabetes have experienced stigma while living with their condition.

How the RMH navigated an aged care outbreak in the middle of Victoria’s second wave News article

During the COVID-19 second-wave, which faced Melbourne in July 2020, multiple aged care wards at the Royal Melbourne Hospital (RMH) faced an outbreak that affected both staff and patients.

Benralizumab for moderate to severe atopic dermatitis Research study

A clinical trial to assess the safety and effectiveness of a new drug called benralizumab for atopic dermatitis (eczema).

Vagus nerve stimulation (VNS) device for the treatment of epilepsy Research study

This post-market study involves collecting information for an already approved VNS device to get detailed information about the outcomes of people receiving the approved treatment.